Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
1,083.041,082.631,099.011,080.59
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
602.38602.38609.75599.75
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
1,242.831,229.311,258.881,220.51
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
1,713.821,715.471,763.111,715.47
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
639.99636.98644.04631.81
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
837.46840.30852.55840.30
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
214.22214.22218.25214.05
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
3,204.383,215.043,217.443,159.90
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
925.38927.91949.76927.91
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
1,442.711,443.011,477.901,443.01
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
2,361.342,391.002,399.182,354.52
NAGE:NASDAQ
Niagen Bioscience Inc
$4.73
-0.63%
(-0.030) 1D
Apr 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
$4.78
High
$4.82
Low
$4.68
Mkt. cap
377.23M
Avg. vol.
988.57K
Volume
0.00
52-wk high
$14.69
52-wk low
$4.16
Beta
2.23
Shares outstanding
80.08M
No. of employees
117
News stories
From sources across the web
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
HeadquartersLos Angeles, California, United States
SectorPersonal care products
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
30.48M
31.12M
33.99M
33.84M
Cost of goods sold
11.15M
10.89M
12.06M
12.14M
Cost of revenue
11.15M
10.89M
12.06M
12.14M
Research and development expenses
1.26M
1.57M
1.80M
1.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.30M
15.47M
15.90M
17.89M
Operating expense
14.56M
17.04M
17.69M
19.60M
Total operating expenses
25.71M
27.93M
29.75M
31.74M
Operating income
4.77M
3.18M
4.24M
2.10M
Other non operating income
-
-
-
-214.00K
EBT including unusual items
5.23M
3.74M
4.80M
4.42M
EBT excluding unusual items
5.23M
3.74M
4.80M
2.44M
Income tax expense
168.00K
128.00K
222.00K
292.00K
Effective tax rate
3.21%
3.43%
4.62%
6.60%
Other operating expenses
-
-
-
-
Net income
5.06M
3.61M
4.58M
4.13M
Net profit margin
16.61%
11.60%
13.47%
12.21%
Earnings per share
0.05
0.04
0.05
0.03
Interest and investment income
459.00K
552.00K
564.00K
552.00K
Interest expense
-
-
-
-
Net interest expenses
459.00K
552.00K
564.00K
552.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
4.97M
3.38M
4.43M
2.30M
Gain or loss from assets sale
4.00K
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more